Gelomics offers photocrosslinkable extracellular matrix kits with tunable mechanical properties for 3D cell and organoid culture, tissue engineering and bioprinting.

Gelomics

🔬 EOFY Sale Alert 📢 Get 20% OFF ALL PRODUCTS!  
Don’t miss out on these incredible savings, offer ends on 30 June 2024. Head over to our website and take advantage of these deals while they last: https://lnkd.in/g_uJ9Vik

Place your order today at info@gelomics.com.

#EOFYSale #LunaCrosslinker #LunaGel #SaveBig

Thanks Boston for a great day visiting partners and new friends following #BIO2024! Enjoyed the beautiful sunshine and the sights with Christoph Meinert, PhD and Gelomics.

Massachusetts Institute of Technology 
Pfizer

Our team had a fantastic opportunity to meet, connect, and partner with some of the most advanced companies in the BIO International Conference 2024 #BIO2024 in beautiful San Diego! We are incredibly proud to be one of the Queensland delegates representing a stronger Queensland in biotechnology.
 
A big thank you to the Queensland Government, Trade and Investment Queensland (TIQ), Life Sciences Queensland Ltd (LSQ), and Brisbane Economic Development Agency for their unwavering support. Together, we are driving innovation and making significant strides in the biotech sector.

Christoph Meinert, PhD Peter Levett
#BIO2024 #Biotechnology #Queensland #Innovation #Partnerships #Gelomics

Gelomics COO Peter Levett and I had an incredible start to #BIO2024 with a warm welcome from Trade and Investment Queensland  
and an inspiring MTPConnect Global #Australia reception in beautiful San Diego ☀️

We're looking forward to the next few days, filled with engaging discussions and partnering meetings. If you're at BIO2024 and interested in animal-free #drugdevelopment, let's connect!

#Gelomics #Innovation #LifeSciences #SanDiego #BIO2024 #Networking #Biotech

🌟 Intern Spotlight: Meet Finja, Our Talented Intern! 

We are delighted to introduce Finja Joerg, a third-year Bachelor Honours student in #Bioprocessing at Dublin City University, who is currently completing an eight-month #internship with us at Gelomics.

Finja is making significant strides in developing high-throughput compatible 3D cell culture systems, crucial for advancing drug discovery and development.

At Gelomics, we are committed to fostering the next generation of innovators in #biotechnology. We are proud to support Finja on her academic and professional journey, and we look forward to seeing the incredible advancements she will achieve in her research.

Join us in celebrating Finja and her outstanding work!

#Gelomics #3DCellCulture #InternSpotlight #DrugDiscovery #FutureInnovators #BiotechResearch #StudentSuccess #STEMInternship #InnovativeResearch

Gelomics is a biotechnology company that specializes in developing 3D tissue culture systems, primarily the LunaGel™ Photocrosslinking Technology, which allows researchers to create highly controlled 3D tissue culture models in minutes for more accurate and predictive research.

COM:GELOMICS

Gelomics

Filings Not Available